These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2945874)

  • 21. Iron binding to anticonvulsants.
    Garzón-de la Mora P; Navarro-Ruíz A; García-Estrada J; Correa E
    Arch Invest Med (Mex); 1984; 15(4):293-301. PubMed ID: 6535516
    [No Abstract]   [Full Text] [Related]  

  • 22. Active metabolites in antiepileptic therapy. Reflections on a pharmacological joker.
    Hvidberg EF
    Acta Neurol Scand Suppl; 1983; 94():9-13. PubMed ID: 6410677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on anticonvulsant level in body fluids. 2nd report: Dialyzed serum (free form), CSF and saliva level (author's transl)].
    Kaneko S
    Seishin Shinkeigaku Zasshi; 1978 Jan; 80(1):29-42. PubMed ID: 662972
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of antiepileptic drugs in the presence of liver and kidney diseases: a review.
    Asconapé JJ; Penry JK
    Epilepsia; 1982; 23 Suppl 1():S65-79. PubMed ID: 6814902
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epileptic mother and her child.
    Philbert A; Dam M
    Epilepsia; 1982 Feb; 23(1):85-99. PubMed ID: 6799286
    [No Abstract]   [Full Text] [Related]  

  • 27. Poor correlation between single-dose data and steady-state kinetics for phenobarbitone, primidone, carbamazepine and sodium valproate in children during monotherapy. Possible reasons for the lack of correlation.
    Armijo JA; Herranz JL; Arteaga R; Valiente R
    Clin Pharmacokinet; 1986; 11(4):323-35. PubMed ID: 3093129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.
    Eadie MJ
    Clin Pharmacokinet; 1991 Jul; 21(1):27-41. PubMed ID: 1914340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Clinical pharmacokinetics of antiepileptic drugs. Quantitative variables of drug clearance used for the individual assessment of dosage regimens.
    Kleijn E; Guelen PJ; Baars I; Vree TB
    Acta Pharm Suec; 1974 Dec; 11(6):663-5. PubMed ID: 1136812
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of pregnancy on seizure threshold and the disposition and efficacy of antiepileptic drugs in the mouse.
    Nau H; Kuhnz W; Löscher W
    Life Sci; 1985 Feb; 36(7):663-9. PubMed ID: 3918226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine replacement of phenytoin, phenobarbital and primidone in a rehabilitation setting: effects on seizure control.
    Wroblewski BA; Glenn MB; Whyte J; Singer WD
    Brain Inj; 1989; 3(2):149-56. PubMed ID: 2499396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of antiepileptic drugs.
    Penry JK; Newmark ME
    Ann Intern Med; 1979 Feb; 90(2):207-18. PubMed ID: 375789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs.
    Streete JM; Berry DJ; Pettit LI; Newbery JE
    Ther Drug Monit; 1986; 8(2):161-5. PubMed ID: 3088778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model.
    Stepien KM; Tomaszewski M; Luszczki JJ; Czuczwar SJ
    Eur J Pharmacol; 2012 Jan; 674(1):20-6. PubMed ID: 22056838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical considerations in anticonvulsant therapy--Part 2.
    Meyer MC; Cloyd J; Garnett WR; Holmes GL; Schiffer JR
    Am Pharm; 1995 Sep; NS35(9):31-6, 40. PubMed ID: 7484814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiepleptic drug interactions: a clinical case demonstration.
    Tesfaye H; Klapková E; Tesfayeová A; Komárek V
    Cas Lek Cesk; 2011; 150(8):451-6. PubMed ID: 22026081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of drug combinations between enzyme-inducing first-generation antiepileptic drugs and inducible drugs in patients with epilepsy.
    Zaccara G; Gualdani E; Policardo L; Palumbo P; Francesconi P
    Epilepsy Behav; 2018 Oct; 87():92-95. PubMed ID: 30126756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants.
    Wilbur R; Kulik FA
    Am J Hosp Pharm; 1981 Aug; 38(8):1138-43. PubMed ID: 6791497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in drug therapy for epilepsy.
    Bruni J
    Can Med Assoc J; 1979 Apr; 120(7):817-24. PubMed ID: 371777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of anticonvulsants.
    Garrettson LK
    Pediatr Clin North Am; 1972 Feb; 19(1):179-91. PubMed ID: 4558884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.